Diabetes mellitus urological complication
Authors:
Miroslava Ryšánková
Authors place of work:
Urologie Náchod, s. r. o.
Published in the journal:
Vnitř Lék 2023; 69(E-2): 26-30
Category:
In Brief
doi:
https://doi.org/10.36290/vnl.2023.026
Summary
Diabetes mellitus is a disease characterized by chronic hyperglycaemia due to an absolute or relative lack of insulin. The disease mainly affects the nervous system, and the urological complications themselves develop on the basis of these disorders. Urological patients with diabetes present in ambulance with manifestations of common urological diseases, but also suffer from complications of the urinary system or genital organs that are specific for diabetic patient. Usually, these complications go unrecognized for a long time or manifest only non-specifically. But they are often life-threatening for patients. Treatment does not consist only in urological stabilization, but stabilization of the diabetes itself is also necessary. It can be said that diabetes increases the risk of urological problems, and on the contrary, urological problems (especially inflammation) can lead to decompensation of the patient’s diabetes.
Keywords:
Fournier’s gangrene – diabetes mellitus – diabetic nephropathy – diabetic cystopathy – emphysematous pyelonephritis – renal papillary necrosis
Zdroje
1. Češka R, et al. Interna. 3. vydání, Praha: Triton, 2020; 970 s.
2. Pelikánová T, Bartoš V. Praktická diabetologie. 6 ed. Praha: Maxdorf, 2018; 815 s.
3. Wein K, Novick PP. Campbell‑Walsh Urology 2007:271-273.
4. Brix AE. Renal papillary necrosis. Toxicol Pathol. 2002;30(6):672-4.
5. Panach‑Navarrete J, Medina‑González M, Lorena Alarcón‑Molero L, et al. Renal papillary necrosis, an endoscopic vision. Scand J Urol. 2019;53(5):361-363.
6. Lacigová S, Rušavý Z, Jirkovská A, et al. Doporučený postup diagnostiky a léčby diabetické neuropatie (2016), Doporučení české diabetické společnosti ČLS JEP, datum revize 23. 2. 2016, dmev; 2016,19(2):57-63.
7. Yuan Z, Tang Z, He Ch, et al. Diabetic cystopathy: A review. J Diabetes. 2015;7(4):442-7.
8. Ryšánková M. Dysfunkce dolních cest močových u diabetického pacienta. Urol. praxi. 2022;23(1):193-7.
9. Wittig L, Carlson KV, Andrews JM, et al. Diabetic Bladder Dysfunction: A Review. Urology. 2019;123:1-6.
10. MINIRIN, Souhrn údajů o přípravku, sp. zn. Sukl s 185737/2018.
11. Lieske JC. Diabetes mellitus and the risk of urinary tract stones: a population‑based case‑ control study. Am J Kidney, DiS. 2006;48:897-904.
12. Broďák M, Romžová M, Košina J. Urologické výkony u diabetika. Vnitr Lek. 2008;54(5):457-463.
13. Venmans LM, Sloof M, Hak E, et al. Prediction of complicated urinary tract infections with type 2 diabetes: a questionnaire study in primary care. Eur J Epidemiol. 2007;22(1):49-54.
14. Hrnčiříková A, Vachek J. Nebezpečné léky u nemocných s renálním poškozením – kdy a jak redukovat dávky. Med. Praxi. 2016;13(4):176-179.
15. Kladenský J. Infekce močových cest a diabetes mellitus. Urol. praxi. 2013;14(2):56-58.
16. Wang Z, Olumi AF. Diabetes, growth hormone‑insulin‑like growth factor pathways and association to benign prostatic hyperplasia. Diferentiation. 2011;82(4-5):261-71.
17. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017-5024.
18. Evans JM, Donnelly LA, Emslie‑Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304-1305.
19. Stone HH, Martin JD Jr. Synergistic necrotizing cellulitis. Ann Surg. 1972;175(5):702-711.
20. Fournier JA. Gangrène‑foudroyante de la verge. Semin Med. 1883;3:345.
21. Tang LM, Su YJ, Lai YC. The evaluation of microbiology and prognosis of fournier’s gangrene in past five years. Springerplus. 2015;4:14.
22. Broďák M, Romžová M, Košina J. Urologické výkony u diabetika. Vnitr Lek. 2008;54(5):457-463.
23. Isidro ML. Sexual dysfunction in men with type 2 diabetes. Postgrad Med J. 2012; 88(1037):152-159.
24. Pederson DF, Latini DM, Lubeck DP, et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than general population of impotent patients? Diabetes Care. 2003;26(4):1093-1099.
25. Haffner SM, Shaten J, Stern MP, et al. Low levels of sex hormo‑ne‑binding globulin and testosterone predict the development of non‑ insulin‑dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143:889-897. Vydáváme knihy
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2023 Číslo E-2
Najčítanejšie v tomto čísle
- Severe autoimune thyreotoxicosis complicated by febrile neutropenia as a result of thyreostatic therapy
- Anemia of inflammatory: does eiderr knowledge mean better diagnosis and treatment?
- Diabetes mellitus urological complication
- Comparison of polypharmacy and pharmacotherapy among seniors in social institutions in 2001 and 2019